Cancer Weekly articles from August 1992

Cancer Weekly archives from August 1992

Machining fluids linked to cancer. (Harvard University)
August 3, 1992... Harvard University A confidential report from Harvard University, Cambridge, Massachusetts, scientists says there is strong evidence that machining fluids used in auto plants are causing cancers and respiratory problems in workers, the...

Prostate cancer risks and treatments differ for HMO vs. fee-for-service patients. (University of Southern California)
August 3, 1992... University of Southern California The chances of surviving prostate cancer may be significantly higher when the disease is treated at a high-quality health maintenance organization (HMO) than when treated through traditional,...

Journal devotes issue to prostate cancer. (CA - A Cancer Journal for Clinicians) (American Cancer Society)
August 3, 1992... American Cancer Society The July/August 1992 issue of CA, the American Cancer Society's journal, is devoted to all aspects of prostate cancer, a disease that is expected to kill 34,000 men in 1992. Prostate cancer is the second most...

'Credit card' reminds women about mammography. (H. Lee Moffitt Cancer Center)
August 3, 1992... H. Lee Moffitt Cancer Center A credit-card style reminder card increases the chances of a repeat mammogram visit, according to a team of researchers from H. Lee Moffitt Cancer Center and Research Institute at the University of South...

Study promised on Long Island breast cancer rate. (New York) (U.S. Centers for Disease Control)
August 3, 1992... U.S. CDC A team of experts appointed by the U.S. Centers for Disease Control (CDC), Atlanta, Georgia, will try to find out why the breast cancer rate on Long Island, New York, is so high. Long Island's breast cancer rate is 13.5...

Results of Phase I trial of breast and ovary cancer treatment. (Biomira Inc.'s Theratope products) (Canada)
August 3, 1992... Canada Biomira Inc., Edmonton, Alberta, Canada, has released results of the Phase I clinical trials of its Theratope products for treatment of cancers of the ovary and breast. The tests, which began in 1990, were concluded recently....

Cancer researcher says chemo-prevention could be on the way. (Curtis Harris) (U.S. National Cancer Institute)
August 3, 1992... U.S. NCI Treatment may soon be available for people who have cancer-related genes but no sign of the disease. Curtis Harris, chief of the U.S. National Cancer Institute's (NCI) human carcinogenesis lab, said scientists have...

Studies of MelVax for melanoma treatment expanded. (ImClone Systems/Memorial Sloan-Kettering)
August 3, 1992... ImClone Systems/Memorial Sloan-Kettering ImClone Systems Inc. and Memorial Sloan-Kettering Cancer Center, New York, New York, announced the expansion of human pilot studies for ImClone's anticancer vaccine MelVax for the treatment of...

Bispecific antibody therapeutic program expanded. (Medarex Inc.)
August 3, 1992... Medarex Inc. Medarex Inc., Princeton, New Jersey, announced that it has expanded its Bispecific monoclonal antibody therapeutic program to develop treatments for melanoma, glioma and neuroblastoma. The new products are based on...

Pain relief at cancer patients' fingertips. (Patient Activated Reservoir device for patient-controlled analgesia) (International Pain & Implants)
August 3, 1992... International Pain & Implants International Pain & Implants (IPI), a corporate brand division of PS Medical, has been granted permission by the U.S. Food and Drug Administration (FDA) to start clinical trials of the Patient Activated...

Physician links cigarette smoking to impotence. (Paul Farr) (Michigan)
August 3, 1992... Michigan Michigan men are being warned that smoking cigarettes could be hazardous to their sex life. In his "Best of Health" radio and TV messages, Paul Farr, M.D., states that although it's common knowledge that cigarette smoking...

Smokers use electrical zapping device to break habit. (NET-I, or neuroelectric therapy instrument) (Colorado)
August 3, 1992... Colorado A small electrical device that looks like a hearing aid and is worn in the ear is being clinically tested on smokers to help them break the habit. It is called NET-I for neuroelectric therapy instrument and was invented by...

Association blasts tobacco tactics. (Tobacco Institute) (American Medical Association)
August 3, 1992... American Medical Association The following statement was released July 22, 1992, by John L. Clowe, M.D., president, American Medical Association: "For the second time in two years, a scientific panel of the federal Environmental...

New hepatitis C test introduced. (Murex Diagnostics Ltd.'s Wellcozyme anti-HCV) (Europe)
August 3, 1992... Europe International Murex Technologies Corp. (IMTC), Toronto, Canada, announced that its major European subsidiary, Murex Diagnostics Ltd. (formerly Wellcome Diagnostics), has begun shipment of a new, unique hepatitis C test into...

Pathway converts chemicals to carcinogens in cells. (Ohio State University)
August 3, 1992... Ohio State University A small alteration in a chemical can sometimes lead to a big change in its ability to cause cancer in animals and human cells. In fact, new research shows that the cancer-causing ability of one particular...

Study examines p53 tumor suppression protein. (Albert Einstein College of Medicine)
August 3, 1992... Albert Einstein College of Medicine A New York study offers evidence that loss of p53 tumor suppressor protein function is an important step in the etiology of human papilloma virus (HPV)-negative cervical cancers, just as it is in HPV+...

Company formed to commercialize FGF receptor products. (fibroblast growth factor; Prizm Pharmaceuticals Inc.) (California)
August 3, 1992... California Principals at Domain Associates, Biotechnology Investments Ltd. and Whittier Institute announced the formation of Prizm Pharmaceuticals Inc., San Diego, California, a new company specializing in the application of fibroblast...

Jury deciding damages in asbestos trial. (Maryland)
August 3, 1992... Maryland A jury began deliberations July 22, 1992, to decide whether six sample plaintiffs in the nation's largest personal injury trial involving asbestos deserve millions of dollars in damages. Baltimore, Maryland, Circuit Court...

Legislators move to protect Pacific yew. (U.S. Congress)
August 3, 1992... U.S. Congress The U.S. Senate sent to President Bush legislation to protect Pacific yew trees, the only source of a promising new cancer drug, from logging in the Northwest United States. The bill, passed by the House two weeks...

Unconventional treatment methods being reviewed. (U.S. National Institutes of Health)
August 3, 1992... U.S. NIH A newly created U.S. National Institutes of Health (NIH) office will evaluate research on unconventional medical treatments for cancer and other diseases. The Office for the Study of Unconventional Medical Practices was...

New bibliography available. (Diagnosis and Treatment of Early Melanoma) (U.S. National Library of Medicine)
August 3, 1992... U.S. National Library of Medicine A new cancer bibliography, prepared by the U.S. National Library of Medicine for its Current Bibliographies in Medicine series, is now available from the U.S. Government Printing Office (GPO). The...

Multi-institutional Phase II study of Navelbine (vinorelbine) in non-small cell lung cancer. (Research Report)
August 3, 1992... Multi-Institutional Phase II Study of Navelbine AUTHORS: A Yokoyama, K. Furuse and H. Niitani. Niigata Cancer Center, Niigata, Japan. According to the authors' abstract of a poster presentation to the 28th annual meeting of the...

Effect of sizofiran (SPG) with radiotherapy on non-small cell lung cancer (NSCLC), results of a prospective randomized controlled study. (Research Report)
August 3, 1992... AUTHORS: T. Okawa, S. Hashimoto, H. Niibe, S. Amino, M. Abe, Y. Onoyama, K. Masuda, M. Nishimura, Y. Nakai, T. Dokiya, M. Fukuoka, H. Furue and N. Ogawa. Cooperative Study Group on SPG in Lung Cancer. According to the authors' abstract...

Chemotherapy in elderly patients with small cell lung cancer (SCLC). (Research Report)
August 3, 1992... AUTHORS: G.D. Goss, D. Logan, J. Maroun, D. Stewart, J. Yau and W.K. Evans. Ottawa Regional Cancer Center, Ottawa, Canada. According to the authors' abstract of a poster presentation to the 28th annual meeting of the American Society of...

Phase II trial of 5-fluorouracil (5-FU) and high dose leucovorin as salvage therapy for epithelial ovarian carcinoma: a Gynecologic Oncology Group study. (Research Report)
August 3, 1992... AUTHORS: L. Look, H.G. Muss, J.A. Blessing and M. Morris. Gynecologic Study Group. According to the authors' abstract of a poster presentation to the 28th annual meeting of the American Society of Clinical Oncology, held May 17-19,...

The use of cisplatin, etoposide and ifosfamide as second line therapy in ovarian carcinoma. (Research Report)
August 3, 1992... AUTHORS: T.R. Baker, M.S. Piver and R.E. Hempling. Roswell Park Cancer Institute, Buffalo, New York. According to the authors' abstract of a poster presentation to the 28th annual meeting of the American Society of Clinical Oncology,...

Genetic finger print analyses in patients with renal carcinomas. (Research Report)
August 3, 1992... AUTHORS: P.E. Petrides, S. Bock, T. Block, M. Rotter, G. Jakes, H. Hofler and W. Wilmanns. University School of Medicine, Munich, Germany. According to the authors' abstract of a poster presentation to the 28th annual meeting of the...

Mammography screening credit card and compliance. (Research Report)
August 3, 1992... AUTHORS: D.V. Schapira, N. Kumar, R. Clark and C. Yag. H. Lee Moffitt Cancer Center and Research Institute and University of South Florida College of Medicine, Tampa, Florida. According to the authors' abstract of a poster presentation...

Male-female differences in the impact of cancer therapy. (Research Report)
August 3, 1992... AUTHORS: C. Gotay, P. Phillips and B. Cheson. The EEMES Corporation and the National Cancer Institute, Bethesda, Maryland. According to the authors' abstract of a poster presentation to the 28th annual meeting of the American Society of...

Leukemia incidence after iodine-131 exposure. (Periodical Report)
August 3, 1992... SOURCE: The Lancet, July 4, 1992;320(8810):1-4. Exposure to iodine131 ([sup131.I]) did not appear to influence the subsequent risk of leukemia in a study of Swedes who were given [sup131.I] for medical reasons, according to the results...

Breast cancer metastases without evidence of a primary tumor. (Periodical Report)
August 3, 1992... SOURCE: Cancer, July 15, 1992;70(2):490-492. Breast cancer patients with minimal or unidentifiable primary carcinoma but extensive involvement of the axillary nodes appear to have a significantly better prognosis than patients with...

The activity of single-agent carboplatin in advanced seminoma. (Periodical Report)
August 3, 1992... SOURCE: European Journal of Cancer, July, 1992;28A (8/9):1307-1310. Advanced seminoma patients treated with single-agent carboplatin at England's Royal Marsden Hospital had survival rates equal to those obtained with initial...

Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. (Periodical Report)
August 3, 1992... SOURCE: Journal of Clinical Oncology, July, 1992;10(7):1191-1200. Selective in vitro T-cell depletion with an anti-T12 monoclonal antibody effectively reduces the incidence of both acute and chronic graft-versus-host disease after...

Menstrual and reproductive factors and breast cancer in women with family histories of the disease. (Periodical Report)
August 3, 1992... SOURCE: International Journal of Cancer, July, 1992;51:703-706. A European case-control study involving more than 5,500 women suggests that neither menstrual nor reproductive factors play an important role in the risk of breast cancer in...

Prognostic relevance of pS2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer. (Periodical Report)
August 3, 1992... SOURCE: European Journal of Cancer, July, 1992;28A (8/9):1315-1319. pS2 gene expression is a predictor of shorter relapse-free survival in node-negative breast cancer patients, but the association does not hold for node-positive women,...

First total laparoscopic radical hysterectomy performed. (Graduate Hospital, Philadelphia, Pennsylvania)
August 10, 1992... Pennsylvania Gynecologic surgeons at the Graduate Hospital in Philadelphia, Pennsylvania, have performed the first total laparoscopic radical hysterectomy, providing cervical cancer patients with a chance to avoid abdominal surgery and a...

Group studying prostate cancer prevention. (Southwest Oncology Group, Texas)
August 10, 1992... Texas About 16,000 men will take a recently approved prostate cancer-fighting drug for 10 years as part of a study to determine whether the remedy also prevents the disease. About one man in 11, mostly those older than 50, will...

Health officials dismiss warnings of HBV epidemic. (hepatitis B) (Sri Lanka)
August 10, 1992... Sri Lanka Anyone who visits Sri Lanka's hospitals and clinics for treatment runs the risk of contracting a fatal strain of jaundice, medical experts warn. The hepatitis B virus (HBV) which attacks the liver is thriving in the...

Patient marks one month with baboon liver. (University of Pittsburgh)
August 10, 1992... University of Pittsburgh The world's first recipient of a baboon liver continues to improve, and the transplanted organ has grown to nearly human size, a University of Pittsburgh surgeon said. The condition of the 35-year-old man...

Results from vaccine to treat malignant melanoma. (John Wayne Cancer Institute)
August 10, 1992... John Wayne Cancer Institute Patients with melanoma, the deadliest form of skin cancer, lived dramatically longer when they were injected with a vaccine-like treatment for the disease, according to a study released July 30, 1992. The...

Throat cancer survivors rate the quality of their reconstructed voices. (Pennsylvania State University)
August 10, 1992... Pennsylvania State University How laryngectomy patients rate the quality of their reconstructed voices speaks volumes about their adjustment to cancer, a Pennsylvania State University, University Park, Pennsylvania, researcher says. ...

Court ruling may prevent woman from getting bone-marrow transplant. (health insurance company won't pay for experimental treatment) (Florida)
August 10, 1992... Florida A cancer patient says a court ruling may keep her from getting the $200,000 bone-marrow transplant doctors say could save her life. U.S. District Judge Roger Vinson of Pensacola sided with Mutual of Omaha, ruling that the...

Insurer must pay for bone-marrow transplant. (California)
August 10, 1992... California An insurance company must honor its original contract and pay for a bone-marrow transplant that could save the life of a cancer-striken Sunnyvale man, a federal judge has ruled. The preliminary injunction granted by U.S....

Cancer deaths at manufacturing facility four time higher than expected. (Lordstown General Motors plant) (Ohio)
August 10, 1992... Ohio The number of cancer deaths among workers at the General Motors Corp.'s Lordstown, Ohio, facility is at least four times greater than expected, according to a company-union study. There are also indications of a...

Cancer rates double among 3M workers compared with area residents. (Minnesota)
August 10, 1992... Minnesota Overall cancer rates are nearly double among 480 former and current building tradesmen at 3M Company, Maplewood, Minnesota, compared with those of area residents, health officials say. Although the state Health Department...

Product warning labels cause for debate. (Ohio)
August 10, 1992... Ohio Ohio Citizen Action committee prepared August 3, 1992, to file a petition with Secretary of State Bob Taft on behalf of a November 3, 1992, ballot dealing with harmful chemicals. Ohio Citizen Action said it was confident that...

Studies on oncogene activation and molecular dosimetry in animal models for chemical carcinogenesis. (National Institute of Environmental Health Sciences research grant announcement) (Research Report)
August 10, 1992... AUTHORS: RFP Available: NIH-ES-92-30. National Institute of Environmental Health Sciences. "The National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), is soliciting proposals from offerers...

Epidemiology of ovarian cancer. (National Cancer Institute research grant announcement) (Research Report)
August 10, 1992... AUTHORS: RFA Available: CA-92-20. National Cancer Institute. "Letter of Intent Receipt Date: October 15, 1992. Application Receipt Date: November 12, 1992. Purpose: The Division of Cancer Etiology of the National Cancer Institute...

Biotechnology transfer to epidemiologic studies in cancer. (National Cancer Institute/ National Institute of Environmental Health Sciences research grant announcement) (Research Report)
August 10, 1992... AUTHORS: RFA Available: CA/ES-92-23. National Cancer Institute, National Institute of Environmental Health Sciences. "Letter of Intent Receipt Date: October 22, 1992. Application Receipt Date: November 19, 1992. Purpose: The...

Transfer of new biostatistic methods to cancer epidemiology. (National Cancer Institute research grant announcement) (Research Report)
August 10, 1992... AUTHORS: RFA Available: CA-92-21. National Cancer Institute. "Letter of Intent Receipt Date: September 30, 1992. Application Receipt Date: November 12, 1992. Purpose: The Division of Cancer Etiology of the National Cancer Institute...

Radiation therapy of HIV positive non-Hodgkin's lymphoma (NHL). (Research Report)
August 10, 1992... AUTHORS: Alfred H. Brandon, Joanne L. Bujnoski, Jeffrey A. Fiedler, Arnold M. Markoe, Evelyn Marienberg, Andre Abitbol, Ahmad M. Boota, Marcio A. Fagundes, Shenghan Lai and James G. Schwade. University of Miami School of Medicine, Miami,...

Targeting of gene therapy with radiation therapy. (Research Report)
August 10, 1992... AUTHORS: R.R. Weichselbaum, D.E. Hallahan, D. Gius, V. Sukhatme, R. Datta and D. Kufe. Howard Hughes Medical Institute, University of Chicago, Chicago, Illinois, and the Dana Farber Cancer Institute, Boston, Massachusetts. According to...

Twenty-year experience in childhood craniopharyngioma: the importance of radiation therapy. (Research Report)
August 10, 1992... AUTHORS: Stella Hetelekidis, May L. Tao, Edwin G. Fischer, Patrick D. Barnes, R. Michael Scott and Nancy J. Tarbell. New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts. According to the authors' abstract of a...

Adjuvant immunotherapy with anti-B4-blocked ricin (Anti-B4-bR) following autologous bone-marrow transplantation (ABMT) for patients with B-cell NHL. (non-Hodgkin's lymphoma) (Research Report)
August 10, 1992... AUTHORS: M.L Grossbard( 1), J.G. Gribben( 1), A.S. Freedman( 1), S.N. Rabinowe( 1), J.M. Kinsella( 1), L. Eliseo( 1), C.L. Epstein( 2), L.M. Nadler( 1). (1)Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts...

Epidermal growth factor receptor mediated cytotoxicity of the fusion toxin DAB389EGF in vitro and in vivo. (Research Report)
August 10, 1992... AUTHORS: J.P. Shaw, N. Kassam, M.M. Cleveland, P.L. Jones, J.C. Nichols and P. Bacha. Seragen, Inc.. Hopkinton, Massachusetts. According to an abstract presented to the Third International Symposium on Immunotoxins, held June 19-21,...

Effect of human recombinant TNF-alpha on localization of 90Y-radioantibody in human tumor xenografts. (tumor necrosis factor) (Research Report)
August 10, 1992... AUTHORS: T. Matsushita, Z. Yao, A.B. Brill and T. Griffin. University of Massachusetts Medical Center, Worchester, Massachusetts 01655. According to an abstract presented to the Third International Symposium on Immunotoxins, held June...

Anti-CD19 enhances the anti-tumor activity of anti-CD22-A immunotoxin in SCID/Daudi mice. (Research Report)
August 10, 1992... AUTHORS: M.A. Ghetie, K. Tucker, J. Uhr and E. Vitetta. Departments of Microbiology and Cancer Immunobiology Center, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas. According to an abstract presented to the...

Cells from patients with chronic lymphocytic leukemia and adult T-cell leukemia are killed by recombinant anti-IL2 receptor toxins. (Research Report)
August 10, 1992... AUTHORS: Robert J. Kreitman( 1), Vijay K. Chaudhary( 2), David J.P. FitzGerald( 1), Thomas A. Waldmann( 3), and Ira Pastan( 1). (1)Laboratory of Molecular Biology, DCBDC, U.S. National Cancer Institute, U.S. National Institutes of Health,...

Cytotoxic effects of ricin A chain immunotoxins directed against defined antigens associated with human small cell lung cancer. (Research Report)
August 10, 1992... AUTHORS: Elaine J. Derbyshire( 1), Rolf A.Stahel( 2), Lou de Leij( 3), Sylvie Menard( 4) and Edward J.Wawrzynczak( 1). (1)Institute of Cancer Research, Sutton, United Kingdom; (2)University Hospital, Zurich, Switzerland; (3)University...

The prognostic significance of elevated serum beta(2) microglobulin (beta-2-M) levels in adult acute lymphocytic leukemia (ALL). (Research Report)
August 10, 1992... AUTHORS: H.M. Kantarjian, T. Smith, E. Estey, S. O'Brian, S. Pierce, M. Beran, E. Feldman and M.J. Keating. M.D. Anderson Cancer Center, Houston, Texas. According to the authors' abstract of a presentation to the 83rd annual meeting of...

The first hours of acute myelogenous leukemia treatment: a unique period to determine the blood life span of leukemic and other white cells. (Research Report)
August 10, 1992... AUTHORS: C. Sauter and M. Zahner. University Hospital, Zurich, Switzerland. According to the authors' abstract of a presentation to the 83rd annual meeting of the American Association for Cancer Research, held May 20-23, 1992, in San...

Double-blind, placebo controlled study of wheat bran fiber (WBF) versus calcium carbonate (CALC) in patients with resected adenomatous polyps. (Research Report)
August 10, 1992... AUTHORS: D. Alberts, S. Rees-McGee, J. Einspahr, N. Mason-Liddil, L. Giordano and J. Phelps. The Arizona Cancer Center, Tucson, Arizona. According to the authors' abstract of a presentation to the 83rd annual meeting of the American...

Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinoma. (Periodical Report)
August 10, 1992... SOURCE: The Lancet, July 18, 1992;340:140-142. Loss of heterozygosity (LOH) on chromosome region 17p13, in which p53 is located, is present in human-papillomavirus-negative cervical cancers, adding to the evidence that loss of normal...

The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction. (Periodical Report)
August 10, 1992... SOURCE: American Journal of Pathology, July, 1992;141(1):193-200. bcl-2 gene translocation does not appear to play an important role in the pathogenesis of Hodgkin's disease, according to a study by Columbia University researchers. ...

Comparison of the effects of all-trans and cis-retinoic acid on the blast stem cells of acute myeloblastic leukemia in culture. (Periodical Report)
August 10, 1992... SOURCE: Leukemia, July, 1992;6(7):656-661. All-trans-retinoic acid appears to be more effective than cis-retinoic acid in inducing blast stem cell self renewal in acute myeloblastic leukemia cultures, according to an Ontario Cancer...

Serum lactate dehydrogenase in childhood neuroblastoma: a Pediatric Oncology Group recursive partitioning study. (Periodical Report)
August 10, 1992... SOURCE: American Journal of Clinical Oncology, July, 1992;15(4):295-30. A Pediatric Oncology Group Study of children with neuroblastoma found four major subsets of patients, with level of serum lactate dehydrogenase (LDH) being a...

Phase II study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma. (Periodical Report)
August 10, 1992... SOURCE: Cancer Research, July 15, 1992;52:3871-3874. Intravenous idarubicin has efficacy in the treatment of previously treated patients with unfavorable non-Hodgkin's lymphoma, according to a multicenter study. Idarubicin...

Prophylactic lymph node dissection in patients with advanced gastric cancer promotes increased survival time. (Periodical Report)
August 10, 1992... SOURCE: Cancer, July 15, 1992;70(2):392-395. Prophylactic lymph node dissection should be routinely undertaken in patients with advanced gastric cancer, according to a report from Japan's Kyushu University. Certain researchers have...

GM-CSF treatment growth factor protects bone marrow, allows more aggressive cancer treatment. (University of Texas/Indiana University)
August 17, 1992... University of Texas/Indiana University A modified chemotherapy schedule using the growth factor GM-CSF (granulocyte macrophage colony-stimulating factor) has been shown to boost and protect bone marrow and allow more aggressive treatment...

Bone-marrow transplant success improves slightly as leukemia treatment. (Wisconsin)
August 17, 1992... Wisconsin Using bone-marrow transplants as a cure for leukemia became modestly more successful during the 1980s, reaching a 57 percent survival rate in cases caught early enough, a new study says. "There's been improvement, but not...

Bone cancer incidence not related to water fluoridation. (U.S. Food and Drug Administration)
August 17, 1992... U.S. FDA A report from U.S. Food and Drug Administration's (FDA) National Center for Toxicological Research finds that an international increase in bone cancers among young males is not related to drinking water fluoridation. The...

Researchers apply positron emission tomography to breast cancer diagnosis and evaluation. (University of California, Los Angeles)
August 17, 1992... University of California, Los Angeles In a pilot clinical trial published in the July 1992 issue of the the Annals of Surgery, researchers at the Revlon/University of California, Los Angeles (UCLA), Women's Cancer Research Program report...

Taxol to be offered to some women with breast cancer. (U.S. National Cancer Institute)
August 17, 1992... U.S. NCI The drug taxol will be offered to some of the thousands of women with advanced cases of breast cancer, a U.S. National Cancer Institute (NCI) scientist said. Clinical trials of taxol against breast cancer have been very...

Bush signs legislation protecting yew tree. (Washington, D.C.)
August 17, 1992... Washington, D.C. President Bush signed into law a measure ensuring that federal lands will be managed to provide for a sustainable harvest of the Pacific yew. Bark from the tree is the only reliable source of taxol, an experimental...

Fat-cancer link to be studied. (American Cancer Society)
August 17, 1992... American Cancer Society The American Cancer Society (ACS) is beginning a study to see if cutting fat in a breast cancer patient's diet will cut the chances of the cancer returning. ACS announced in Glens Falls, New York, that the...

Researchers link thyroid disorders to nuclear tests. (Utah )
August 17, 1992... Utah A U.S. National Cancer Institute (NCI) study confirms a weak link between open-air atomic weapons tests and thyroid disease in Utahans and Nevadans living downwind. Researchers found increased incidents of thyroid "neoplasms"...

Radar gun cancer link concerns police. (Washington, D.C.)
August 17, 1992... Washington, D.C. Citing concerns by police about potentially cancerous side effects from using traffic radar guns, a senator is urging federal regulatory agencies to investigate whether current safety standards for microwave radiation...

Cancer center uses vitamin A derivative for treatment. (trans-retinoic acid) (University of California, Irvine)
August 17, 1992... University of California, Irvine Patients diagnosed with advanced melanoma, brain or head and neck cancers now have a second chance in their fight for survival. Doctors at the University of California, Irvine, (UCI) Clinical Cancer...

Predictive testing for familial cancers must be addressed. (U.S. National Cancer Institute)
August 17, 1992... U.S. NCI The question of whether to test family members of cancer patients with germ-line p53 mutations, for the mutations, is a complicated one which must be addressed, according to the researchers who identified a familial disorder...

Two million California non-smokers exposed to second-hand smoke in the workplace in 1990. (American Medical Association)
August 17, 1992... American Medical Association Smokers who work in an area without a smoking policy or with one not covering the work area were more than eight times more likely to be exposed to environmental tobacco smoke (ETS) than those who worked in a...

First nicotine patch for waking hours use introduced. (Nicotrol) (Parke-Davis)
August 17, 1992... Parke-Davis The Parke-Davis division of Warner-Lambert Company, Morris Plains, New Jersey, announced that its new nicotine patch, Nicotrol (nicotine transdermal system), will be available by prescription in pharmacies in mid-August 1992....

NIH director redirects cancer funds. (National Institutes of Health; Bernadine Healy) (U.S. National Cancer Institute)
August 17, 1992... U.S. NCI The Journal of the National Cancer Institute (JNCI) reports that U.S. National Institutes of Health (NIH) director Bernadine Healy has redirected $16 million from the U.S. National Cancer Institute (NCI) budget to go to cancer...

Physicians need more hospice training. (National Cancer Advisory Board)
August 17, 1992... National Cancer Advisory Board Many advanced cancer patients do not take advantage of palliative care provided by the growing number of hospices around the country because too few doctors are referring patients to the programs, officials...

Pilot trial of anti-idiotypic monoclonal antibody BEC2 in patients with metastatic melanoma. (Research Report)
August 17, 1992... AUTHORS: P.B. Chapman, P.O. Livingston, T.A. Steffens, H.F. Oettgen and A.N. Houghton. Memorial Sloan Kettering Cancer Center, New York, New York. According to the authors' abstract of a presentation to the 83rd annual meeting of the...